Pharmacierge, the leader in private e-prescription app and delivery services announces its forthcoming expansion within the heart of London’s healthcare district.
Jerry Temko, Managing Director, In-House Counsel Group, Major, Lindsey & Africa explores how Life science companies are becoming more alive to the role that in-house legal teams will play in safely and successfully taking on the AI challenge.
Charles Collins-Chase, partner, and Harry Muttock, associate, at international IP law firm, Finnegan, explore AI’s potential and how companies can use IP to protect their investments in AI technology.
James Zaremba, sales director at automation specialist COPA-DATA, explains how specialised software can help to navigate the complexities of the new generation of smart pharmaceutical manufacturing.
Editor, Rebekah Jordan, sat down with Dr. Gen Li, president and co-founder of Phesi, to learn more about how the company’s AI-driven clinical database is allowing insights and observations to be drawn from big clinical trial data.
Chuck Miller, director of Solution Consulting, AspenTech, gives five important ways technology and automation can support pharma companies with mitigating increased complexity and seizing opportunities in the year ahead.
EPM conducted a roundtable with several pharma experts to learn what pharma industry trends to watch out for in 2023, from AI drug discovery through to the rise of decentralised trials.
With AI becoming more prevalent in the pharma space, Raman Bhatnagar, Pharmaceuticals lead, Aspen Technology, explores the power of machine learning and analytics, and how this helps anticipate failure prediction in pharma manufacturing.
Shafique Virani, chief corporate development officer and interim chief medical officer, Recursion, delves into digital transformation within drug discovery and the power of AI-enabled platforms in the future of therapeutics.
